Evidence map›Paper›PMID 28073939›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Nanoscale Molecular Reorganization of the Inhibitory Postsynaptic Density Is a Determinant of GABAergic Synaptic Potentiation.

Francesca Pennacchietti, Sebastiano Vascon, Thierry Nieus, Christian Rosillo, Sabyasachi Das, Shiva K Tyagarajan, Alberto Diaspro, Alessio Del Bue, Enrica Maria Petrini, Andrea Barberis and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 110 citations in OpenAlex.

  1. GABASynapse (New York, N.Y.) · 2026
    Review
  2. Article
  3. Article
  4. Neuroligin-2-Dependent Adhesion Defines a Molecular Checkpoint for Inhibitory Synaptic Plasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  5. Neuronal Calcium Signaling and Cytoskeletal Dynamics in Neurodegeneration.International journal of molecular sciences · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Structural and functional reorganization of inhibitory synapses by activity-dependent cleavage of neuroligin-2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Francesca PennacchiettiNanoscopy Department.
Sebastiano VasconPattern Analysis and Computer Vision Department.
Thierry NieusNeuroscience and Brain Technologies Department, and.ORCID 0000-0001-8708-1015
Christian RosilloNeuroscience and Brain Technologies Department, and.ORCID 0000-0002-2841-0445
Sabyasachi DasNeuroscience and Brain Technologies Department, and.
Shiva K TyagarajanInstitute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland, and.ORCID 0000-0003-0074-1805
Alberto DiasproNanoscopy Department.
Alessio Del BuePattern Analysis and Computer Vision Department.ORCID 0000-0002-2262-4872
Enrica Maria PetriniNeuroscience and Brain Technologies Department, and.ORCID 0000-0001-5168-4148
Andrea BarberisNeuroscience and Brain Technologies Department, and andrea.barberis@iit.it francesca.cella@iit.it.ORCID 0000-0002-5054-6517
Francesca Cella ZanacchiNanoscopy Department, andrea.barberis@iit.it francesca.cella@iit.it.
BM-Science · FIItalian Institute of Technology · ITControl Vision (United States) · USInternational Institute of Refrigeration · FRUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gephyrin is a key scaffold protein mediating the anchoring of GABAA receptors at inhibitory synapses. Here, we exploited superresolution techniques combined with proximity-based clustering analysis and model simulations to investigate the single-molecule gephyrin reorganization during plasticity of inhibitory synapses in mouse hippocampal cultured neurons. This approach revealed that, during the expression of inhibitory LTP, the increase of gephyrin density at postsynaptic sites is associated with the promoted formation of gephyrin nanodomains. We demonstrate that the gephyrin rearrangement in nanodomains stabilizes the amplitude of postsynaptic currents, indicating that, in addition to the number of synaptic GABAA receptors, the nanoscale distribution of GABAA receptors in the postsynaptic area is a crucial determinant for the expression of inhibitory synaptic plasticity. In addition, the methodology implemented here clears the way to the application of the graph-based theory to single-molecule data for the description and quantification of the spatial organization of the synapse at the single-molecule level.

Indexed as

6-Cyano-7-nitroquinoxaline-2,3-dioneAlgorithmsAnimalsCarrier ProteinsCells, CulturedComputer SimulationExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsFemaleGABAergic NeuronsHippocampusLong-Term Synaptic DepressionMaleMembrane ProteinsMiceMice, Inbred C57BL2-amino-5-phosphopentanoic acid6-Cyano-7-nitroquinoxaline-2,3-dioneCarrier ProteinsExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGATgephyrinMembrane ProteinsN-MethylaspartatePeptidesPolymersReceptors, GABA-AValineclusteringGABAA receptorsgephyrinmodel simulationsPALMplasticitySTORM

Identifiers

PMID28073939
PMCPMC6589977
OpenAlexW2571120430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.